Consolidated Statements of Cash Flows - USD ($) $ in Thousands	12 Months Ended
	Oct. 31, 2024	Oct. 31, 2023	Oct. 31, 2022
Operating activities:
Net income (loss)	$ 16,933	$ (575)	$ 69,244
Adjustments to reconcile net income (loss) to net cash provided by operating activities:
Net loss (gain) on sale of Maryland properties	356	1,003	(68,771)
Depreciation	2,981	2,944	3,995
Amortization	647	612	1,104
Stock based compensation expense	1	11	1,192
Directors fees and related interest paid in stock units		26	120
Stock awards granted to directors	141	140
Loss on investment in tenancy-in-common	170	271	228
Deferred rents - straight line rent	118	100	(18)
Deferred real estate tax appeal fees			35
Bad debt expense	116	16	361
Accreted interest on investment in U.S. Treasury securities	(801)	(353)
Changes in operating assets and liabilities:
Tenants' security accounts	(57)	(23)	(754)
Accounts receivable, prepaid expenses and other assets	(48)	152	2,571
Accounts payable, accrued expenses and deferred director compensation payable	(448)	(1,954)	(1,159)
Deferred revenue	54	311	(786)
Due to affiliate - accrued interest			(47)
Net cash provided by operating activities	20,163	2,681	7,315
Investing activities:
(Cash outlays) proceeds from sale of Maryland properties, net	(356)	(1,003)	245,763
Purchase of U.S. Treasury securities	(45,663)	(38,444)
Proceeds from maturities of U.S. Treasury securities	40,786	15,204
Proceeds from payment of secured loans receivable inclusive of accrued interest			5,316
Capital improvements - existing properties	(1,242)	(1,290)	(1,570)
Deferred leasing costs	(89)	(170)	(173)
Distribution from investment in tenancy-in-common	455	390	357
Net cash (used in) provided by investing activities	(6,109)	(25,313)	249,693
Financing activities:
Repayment of mortgages	(9,308)	(26,538)	(194,559)
Proceeds from mortgage loan refinancings		25,500	32,500
Proceeds from exercise of stock options	38	1,263	2,028
Deferred financing costs	(206)	(481)	(691)
Due to affiliate - loan proceeds			300
Due to affiliate - loan repayment			(3,505)
Dividends paid	(1,491)	(13,721)	(53,535)
Distributions to noncontrolling interests in subsidiaries	(2,220)	(3,535)	(20,091)
Net cash used in financing activities	(13,187)	(17,512)	(237,553)
Net increase (decrease) in cash, cash equivalents and restricted cash	867	(40,144)	19,455
Cash, cash equivalents and restricted cash, beginning of year	18,356	58,500	39,045
Cash, cash equivalents and restricted cash, end of year	19,223	18,356	58,500
Supplemental disclosure of cash flow data:
Interest paid	6,783	7,182	7,134
Investing activities:
Accrued capital expenditures, construction costs and pre-development costs	237	210	33
Financing activities:
Dividends declared but not paid	5,224	372	10,573
Dividends paid in share units			1,741
The following table provides a reconciliation of cash, cash equivalents and restricted cash reported within the consolidated balance sheets:
Cash and cash equivalents	14,914	13,217	49,578
Tenants' security accounts	913	962	1,038
Funds held in post-closing escrow		883	6,251
Mortgage escrows (included in prepaid expenses and other assets)	3,396	3,294	1,633
Total cash, cash equivalents and restricted cash	$ 19,223	$ 18,356	$ 58,500